Global Peptide CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A Peptide Contract Development and Manufacturing Organization (CDMO) is a specialized company that offers comprehensive services for the development, production, and manufacturing of peptides. Peptides are short chains of amino acids that play a crucial role in various biological processes and are used in a wide range of applications, including pharmaceuticals, diagnostics, and research. Peptide CDMOs work with pharmaceutical and biotechnology companies to provide expertise in peptide synthesis, process development, quality control, and large-scale manufacturing. They can assist in all stages of peptide development, from early research and development to the commercial production of peptide-based products. Peptide CDMOs play a vital role in accelerating the development of peptide-based drugs and therapies, ensuring high-quality production, and meeting the regulatory requirements of the pharmaceutical industry.

According to DIResearch's in-depth investigation and research, the global Peptide CDMO market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peptide CDMO include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peptide CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peptide CDMO Include:

Bachem

PolyPeptide

CordenPharma

AmbioPharm

USV Peptides

Thermofischer

Bio Basic

JPT

Genscript

Xinbang Pharma

ScinoPharm

SN Biopharm

CBL

Piramal Pharma

CPC Scientific

Peptide CDMO Product Segment Include:

APIs and Intermediates

FDF

Peptide CDMO Product Application Include:

Commercial

Academic Research

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Peptide CDMO Industry PESTEL Analysis

Chapter 3: Global Peptide CDMO Industry Porter's Five Forces Analysis

Chapter 4: Global Peptide CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global Peptide CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Peptide CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Peptide CDMO Market Overview

1.1 Product Definition and Statistical Scope

1.2 Peptide CDMO Product by Type

1.2.1 Global Peptide CDMO Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 APIs and Intermediates

1.2.3 FDF

1.3 Peptide CDMO Product by Application

1.3.1 Global Peptide CDMO Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Commercial

1.3.3 Academic Research

1.4 Global Peptide CDMO Market Revenue Analysis (2019-2030)

1.5 Peptide CDMO Market Development Status and Trends

1.5.1 Peptide CDMO Industry Development Status Analysis

1.5.2 Peptide CDMO Industry Development Trends Analysis

2 Peptide CDMO Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Peptide CDMO Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Peptide CDMO Market Analysis by Regions

4.1 Peptide CDMO Overall Market: 2023 VS 2024 VS 2030

4.2 Global Peptide CDMO Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Peptide CDMO Revenue and Market Share by Region (2019-2024)

4.2.2 Global Peptide CDMO Revenue Forecast by Region (2025-2030)

5 Global Peptide CDMO Market Size by Type and Application

5.1 Global Peptide CDMO Market Size by Type

5.2 Global Peptide CDMO Market Size by Application

6 North America

6.1 North America Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Peptide CDMO Market Size by Type

6.4 North America Peptide CDMO Market Size by Application

6.5 North America Peptide CDMO Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Peptide CDMO Market Size by Type

7.4 Europe Peptide CDMO Market Size by Application

7.5 Europe Peptide CDMO Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Peptide CDMO Market Size by Type

8.4 China Peptide CDMO Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Peptide CDMO Market Size by Type

9.4 APAC (excl. China) Peptide CDMO Market Size by Application

9.5 APAC (excl. China) Peptide CDMO Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Peptide CDMO Market Size by Type

10.4 Latin America Peptide CDMO Market Size by Application

10.5 Latin America Peptide CDMO Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Peptide CDMO Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Peptide CDMO Market Size by Type

11.4 Middle East & Africa Peptide CDMO Market Size by Application

11.5 Middle East & Africa Peptide CDMO Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Peptide CDMO Market Revenue by Key Manufacturers (2020-2024)

12.2 Peptide CDMO Competitive Landscape Analysis and Market Dynamic

12.2.1 Peptide CDMO Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bachem

13.1.1 Bachem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bachem Peptide CDMO Product Portfolio

13.1.3 Bachem Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 PolyPeptide

13.2.1 PolyPeptide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 PolyPeptide Peptide CDMO Product Portfolio

13.2.3 PolyPeptide Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 CordenPharma

13.3.1 CordenPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 CordenPharma Peptide CDMO Product Portfolio

13.3.3 CordenPharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 AmbioPharm

13.4.1 AmbioPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 AmbioPharm Peptide CDMO Product Portfolio

13.4.3 AmbioPharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 USV Peptides

13.5.1 USV Peptides Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 USV Peptides Peptide CDMO Product Portfolio

13.5.3 USV Peptides Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Thermofischer

13.6.1 Thermofischer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Thermofischer Peptide CDMO Product Portfolio

13.6.3 Thermofischer Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Bio Basic

13.7.1 Bio Basic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Bio Basic Peptide CDMO Product Portfolio

13.7.3 Bio Basic Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 JPT

13.8.1 JPT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 JPT Peptide CDMO Product Portfolio

13.8.3 JPT Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Genscript

13.9.1 Genscript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Genscript Peptide CDMO Product Portfolio

13.9.3 Genscript Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Xinbang Pharma

13.10.1 Xinbang Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Xinbang Pharma Peptide CDMO Product Portfolio

13.10.3 Xinbang Pharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 ScinoPharm

13.11.1 ScinoPharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 ScinoPharm Peptide CDMO Product Portfolio

13.11.3 ScinoPharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 SN Biopharm

13.12.1 SN Biopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 SN Biopharm Peptide CDMO Product Portfolio

13.12.3 SN Biopharm Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 CBL

13.13.1 CBL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 CBL Peptide CDMO Product Portfolio

13.13.3 CBL Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Piramal Pharma

13.14.1 Piramal Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Piramal Pharma Peptide CDMO Product Portfolio

13.14.3 Piramal Pharma Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 CPC Scientific

13.15.1 CPC Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 CPC Scientific Peptide CDMO Product Portfolio

13.15.3 CPC Scientific Peptide CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Peptide CDMO Industry Chain Analysis

14.2 Peptide CDMO Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Peptide CDMO Typical Downstream Customers

14.4 Peptide CDMO Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support